Literature DB >> 34272695

Crystal Structures of Drug-Metabolizing CYPs.

D Fernando Estrada1, Amit Kumar2, Christopher S Campomizzi2, Natalie Jay2.   

Abstract

The complex enzyme kinetics displayed by drug-metabolizing cytochrome P450 enzymes (CYPs) (see Chapter 9 ) can, in part, be explained by an examination of their crystallographic protein structures. Fortunately, despite low sequence similarity between different families of drug-metabolizing CYPs, there exists a high degree of structural homology within the superfamily. This similarity in the protein fold allows for a direct comparison of the structural features of CYPs that contribute toward differences in substrate binding, heterotropic and homotropic cooperativity, and genetic variability in drug metabolism. In this chapter, we first provide an overview of the nomenclature and the role of structural features that are common in all CYPs. We then apply these definitions to understand the different substrate specificities and functions in the CYP3A, CYP2C, and CYP2D families of enzymes.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Crystal structure; Cytochrome P450; Ligand binding; SNP; Substrate selectivity

Year:  2021        PMID: 34272695     DOI: 10.1007/978-1-0716-1554-6_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  61 in total

1.  The juxtamembrane sequence of cytochrome P-450 2C1 contains an endoplasmic reticulum retention signal.

Authors:  E Szczesna-Skorupa; B Kemper
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

2.  The cytoplasmic and N-terminal transmembrane domains of cytochrome P450 contain independent signals for retention in the endoplasmic reticulum.

Authors:  E Szczesna-Skorupa; K Ahn; C D Chen; B Doray; B Kemper
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

3.  Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5.

Authors:  D Fernando Estrada; Andria L Skinner; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

4.  Crystal structure of human cytochrome P450 2C9 with bound warfarin.

Authors:  Pamela A Williams; Jose Cosme; Alison Ward; Hayley C Angove; Dijana Matak Vinković; Harren Jhoti
Journal:  Nature       Date:  2003-07-13       Impact factor: 49.962

5.  Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding.

Authors:  Emily E Scott; Mark A White; You Ai He; Eric F Johnson; C David Stout; James R Halpert
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

6.  An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.

Authors:  Emily E Scott; You Ai He; Michael R Wester; Mark A White; Christopher C Chin; James R Halpert; Eric F Johnson; C David Stout
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-16       Impact factor: 11.205

7.  Role of the highly conserved threonine in cytochrome P450 2E1: prevention of H2O2-induced inactivation during electron transfer.

Authors:  Yasushi Yoshigae; Ute M Kent; Paul F Hollenberg
Journal:  Biochemistry       Date:  2013-06-28       Impact factor: 3.162

8.  Human Cytochrome P450 1A1 Adapts Active Site for Atypical Nonplanar Substrate.

Authors:  Aaron G Bart; Ryan H Takahashi; Xiaojing Wang; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2019-11-22       Impact factor: 3.922

9.  ChannelsDB: database of biomacromolecular tunnels and pores.

Authors:  Lukáš Pravda; David Sehnal; Radka Svobodová Vareková; Veronika Navrátilová; Dominik Toušek; Karel Berka; Michal Otyepka; Jaroslav Koca
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation.

Authors:  Javier L Baylon; Ivan L Lenov; Stephen G Sligar; Emad Tajkhorshid
Journal:  J Am Chem Soc       Date:  2013-05-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.